Similar documents
Managing the Low Output Low Gradient Aortic Stenosis Patient

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

Cases in Stress Echo DISCLOSURE

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

March yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

Low Gradient Severe? AS

J. Schwitter, MD, FESC Section of Cardiology

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

CASES IN ADVANCED IMAGING

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

Case Presentations TAVR: The Good Bad and The Ugly

Stress Testing in Valvular Disease

DISCLOSURE. Relevant Financial Relationship(s) Off Label Usage. None. None

Aortic Valvular Stenosis

Aortic stenosis aetiology: morphology of calcific AS,

Sténose aortique à Bas Débit et Bas Gradient

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

Cases of Abnormal Prosthetic Valves

Case Presentation #1

Case based learning: CMR in Heart Failure

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

DISCLOSURE. Echocardiography in Systemic Diseases: Questions. Relevant Financial Relationship(s) None. Off Label Usage None 5/7/2018

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Complications of Myocardial Infarction

Getting the Most Out of Stress Echo

CCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD. Teo et al, Canadian Journal of Cardiology 2014;30:

Low Gradient AS: Multi-Imaging Modalities

Aortic Stenosis Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Rational use of imaging for viability evaluation

Clinical Summary. Live Cases I - IX

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Michigan Society of Echocardiography 30 th Year Jubilee

Affecting the elderly Requiring new approaches. Echocardiographic Evaluation of Hemodynamic Severity. Increasing prevalence Mostly degenerative

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University

The use of Cardiac CT and MRI in Clinical Practice

Stress Echo Cases Sunday, October 8, :10 3:30 PM 20 min

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

2/26/2013. NCDR.13 Case Scenario Presentation Cath PCI Registry. Disclosures. Objectives. Dashboard Implications of Some Major Metrics

Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV?

Clinical Summary. Live Cases I - IX

Conflict Disclosures. Vermont Cardiac Network. Outline. Series Learning Objectives 4/27/2016. Scott E. Friedman April 28, 2016

Echocardiographic Evaluation of Aortic Valve Prosthesis

Aortic Valve Replacement Improves Outcome in Patients with Preserved Ejection Fraction: PRO!

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand

Form 4: Coronary Evaluation

Acute Myocardial Infarction

Ve V rmont rmon Card Car iac d Netw Ne ork tw Scott E. Friedman April 28, 2016

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Cardiac Care Network of Ontario

Disclosures. Stress Echocardiography 2010 Appropriate Use & Further Applications. Stress Echo Clinical Utility 9/8/10

Usually we DON T need to go beyond the gradient

UPMCJAM XCCU CCU 10 PORTERFIELD, CAROL R COLEMAN MD, SILVIA E General

TAVR: Echo Measurements Pre, Post And Intra Procedure

Stress Testing:Which Study is Indicated for My Patient?

Difficult Data Definitions and Scenario s

Constrictive/Restrictive Cardiomyopathies: Diagnosis and Management Update; Radiation Induced Heart Disease. Alexander (Sandy) Dick, MD

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

Radiologic Assessment of Myocardial Viability

Coronary interventions

Indicator Mild Moderate Severe

Form 4: Coronary Evaluation

Culprit vs Multivalve Transcatheter Intervention

Cardiology Cath Conference

Cardiac Perioperative Risk Assessment American Heart Association Guidelines

Stable Angina: Indication for revascularization and best medical therapy

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization

History of Stress Testing. Disclosure. Overview. Stress Echocardiography New Applications. and Comparison with Other Stress.

That unprotected LM: To STENT or NOT to STENT. Vasilios Papademetriou, MD Professor of Medicine Georgetown University

Peripheral Arterial Disease Medical Approach and Management

TEE guided TAVR using BASILICA technique in patient with stenotic Freestyle aortic bioprosthesis

Low Gradient AS Normal LVEF

CABG Surgery following STEMI

Valvular Heart Disease: Assessment and Timing of Intervention. Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust

was admitted to the Cardiology Service at the from Y /M /D to Y / M / D under the care of Dr..

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

12 th Annual West Virginia ACC Meeting April 8, 2017

Richard Grocott Mason

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Robotic & Hybrid Coronary Revascularization

Revascularization Strategies in Patients with Severe LV Dysfunction

Clinical Outcome in Patients with Aortic Stenosis

Severe aortic stenosis should be operated before symptom onset CONTRA. Helmut Baumgartner

Assessment Of Myocardial Viability

Chronic Primary Mitral Regurgitation

Choose the grading of diastolic function in 82 yo woman

CHRONIC CAD DIAGNOSIS

STEMI ST Elevation Myocardial Infarction

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Pearls & Pitfalls in nuclear cardiology

Interventions in the Elderly

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Chronic Total Occlusion: A case for coronary artery bypass grafting

Severe Aortic Stenosis in Elderly Patients: Surgical Versus Transcatheter Aortic Valve Replacement (TAVR)

New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations

Transcription:

Stress Echocardiography: Illustrative Cases Sunil Mankad, MD, FACC, FCCP, FASE Associate Professor of Medicine Mayo Clinic College of Medicine Director, Transesophageal Echocardiography Associate Director, Cardiology Fellowship Mayo Clinic, Rochester, MN mankad.sunil@mayo.edu

DISCLOSURE Relevant Financial Relationship(s) None Off Label Usage None

Dobutamine Echo and Prediction of LV Recovery 100 89 86 98 90 % 80 60 40 74 68 Sensitivity Specificity 27 56 20 0 Biphasic Any improvement Qureshi: Circ, 2/4/97 DSE

Improvement Throughout Study with Dobutamine

Biphasic Response with Dobutamine

Cases 1. Soccer coach receives a red card 2. Let Lord Murphy Reign 3. Bigger is not always better 4. Very Tight 5. Two for the price of one 6. Go With the Flow

Case: 51 yo male, soccer coach New onset chest pain while biking No CV risk factors Referred for Exercise Echo 12 minutes on Bruce Protocol 118% FAC 13 METS Fatigue Positive ECG Flat BP response: 158/92 to 160/84 mmhg

Exercise Echo Rest Exercise 4ch LV LV 2ch

Exercise Echo Rest Exercise 5ch LV LV SA

What does the Exercise Echo show? 1. Normal 2. Inferior ischemia 3. Circumflex ischemia 4. LAD ischemia 5. Multivessel disease

Catheterization Post stent

Case: 67 yo male Referred for pre-op clearance for 7 cm Thoracic Aortic Aneurysm repair No cardiac hx (no CP, no dyspnea) HTN, hyperlipidemia, obesity, ex-smoker Sedentary lifestyle exercise involves getting up from sofa to get TV remote controller Referred for dobutamine stress echo

Dobutamine Stress Echo 4 Ch View Baseline 10 mcg/kg/min LV LV LV LV

Dobutamine Stress Echo 3 Ch View Baseline 10 mcg/kg/min LV LV LV LV

Dobutamine Stress Echo 2 Ch View

Dobutamine Stress Echo Short Axis View

What does the DSE show? 1. Normal 2. Inferior, Inferolateral Ischemia 3. Anterior ischemia 4. Apical ischemia

Cx Cath

67 yo male pre-op for TAA repair Multivessel CAD, diffuse disease Medical Rx TAA repair 28-mm woven Hemashield graft Rocky post-op course; delayed extubation, afib, elevated troponin, worsening of inferolateral RWMA on echo d/c d after 16 day hospitalization 1 yr later: dx d with metastatic stomach CA Hospice

70 year old male with dyspnea on exertion PMH DM HTN Hyperlipidemia Referred for exercise echo

Exercise Echocardiogram 5ch Rest Rest 4ch 5ch Immediately Postexercise Stress 4ch SA 2ch SA 2ch

What does the DSE show? 1. Normal 2. RCA ischemia 3. Circumflex ischemia 4. Mutlivessel ischemia

Exercise Echocardiogram 5ch Rest Rest 4ch 5ch Immediately Postexercise Stress 4ch SA 2ch SA 2ch LVEF: 60 to 50% LV size: Dilatation

High grade stenosis of the left anterior descending and 1st diagonal coronary arteries

40 Year Old Executive Male Heartburn and eructation with exertion HTN Hyperlipidemia Smoker Referred for exercise echo 6 minutes on Bruce Protocol heartburn and positive EKG changes

Exercise Echocardiogram LV LV

Exercise Echocardiogram

What does the DSE show? 1. Normal 2. RCA ischemia 3. Circumflex ischemia 4. LAD ischemia

Cath

Cath: Post Stenting

64 yo male, engineer from Bagdad with chest pain Hx PTCA, DES to D1 and LAD ASA, Plavix, Cardiac rehab Returns 1 yr later; asymptomatic, but sedentary, wants ex echo? Medication compliance

64 yo male, engineer, Hx stent to D1/LAD

64 yo male, engineer with chest pain

What does the DSE show? 1. Normal 2. RCA ischemia 3. Circumflex ischemia 4. LAD/D1 ischemia 5. Non-diagnostic study

What does the cath show?

Case 70 year old male PMH: Anteroapical MI, CABG after MI ICD placed: NSVT, EF 30% Asymptomatic for 5 years Now presents with CHF, NYHA class III Physical Exam: Grade 3/6 late peaking SEM Diminished carotid upstroke Single component S2

2D Echo: Severe LV Dysfunction EF: 20%

Aortic Valve Parasternal Long-Axis Parasternal Short-Axis

Aortic Valve Gradient Pk Gr = 27 mmhg Mn Gr = 14 mmhg AVA = 0.8 cm2

Coronary Angiogram Patent LIMA Patent SVG to OM1 Occluded LAD 90% proximal Left Circumflex stenosis No significant disease in RCA Viability Study: Apical scar, all other areas viable

Question What would you do next? A. Aortic valvuloplasty B. Refer to CT Surgery for AVR C. Dobutamine stress study D. Prayer

Dobutamine in Low Gradient- Low EF Aortic Stenosis True severe AS SV, transvalvular gradient; No change in calculated AVA remains in severe range Pseudo severe AS SV and AVA; No significant transvalvular gradient

Baseline Pseudo Aortic Stenosis Dobutamine AVA 0.8 cm 2 1.3 cm 2 Stroke volume TVI 8 cm TVI 16 cm 30 60 cc Mean gradient TVI 42 cm Dimensionless Index = 0.19 TVI 51 cm Dimensionless Index = 0.31 13 19 mmhg Eleid M, Mankad S et al. Heart Fail Rev. 2012

True Low Gradient/Low EF Aortic Stenosis Baseline Dobutamine Stroke volume 40 60 cc Frederick-04-still.jpg Mean gradient 25 40 mmhg Dimensionless Index = 0.22 Dimensionless Index = 0.23 AVA = 0.7 cm 2 Eleid M, Mankad S et al. Heart Fail Rev. 2012

Yes 15 patients 21 pt AVR Contractile reserve Increase in SV >20% Periop mortality 7% 12 survive Class I-II 2 late deaths Non-cardiac

Yes 15 patients 21 pt AVR Contractile reserve No 6 patients In pt with LV systolic dysfunction and AS with a Periop low output and a low MG, dobutamine Periop mortality challenge 7% may aid in selecting mortality those 33% who would benefit from an AV operation. 2 late deaths 2 late deaths Circulation Non-cardiac 2002; 106: 809-813 CHF 12 survive Class I-II 2 survive Class I-II Nishimura: Circulation, 2002

Low Gradient Aortic Stenosis Monin et al - Circulation 2003; 108:319-24 136 AS pt - AVA 0.7, MG 29 mmhg LV contractile reserve assessed by DSE Present in 92 (Group I) Absent in 44 (Group II)

Kaplan-Meier Survival Estimates by Group and Treatment 100 75 Operative Mortality 5% Group I Valve replacement Pt survival (%) 50 25 0 Operative Mortality 32% Group II Valve replacement Group I Medical treatment Group II Medical treatment 0 25 50 75 100 Follow-up (mo)

Case: Results of Dobutamine Stress Echo V1 TVI (cm) V2 TVI (cm) AVA (cm2) Baseline 13 47 0.86 25/14 5 mcg/kg/min dobutamine 10 mcg/kg/min dobutamine 20 mcg/kg/min dobutamine 14 47 0.93 25/14 15 53 0.88 31/16 15 53 0.88 33/17 Peak/Mean AV Gradient (mmhg) * No significant change in EF during study

Change in LVEF after AVR Severe AS with low EF 80 60 Contractile Reserve No Contractile Reserve % 40 47 47.5 20 28 31 0 Before AVR After AVR Quere, J.-P. et al. Circulation 2006;113:1738-1744

Influence of Contractile Reserve in Low-gradient AS Absence of CR related to operative mortality, but it does not predict the absence of LVEF recovery in pt surviving AVR These data further support the concept that surgery should not be contraindicated on the basis of absence of CR alone Quere, J.-P. et al. Circulation 2006;113:1738-1744

Take Home Points Dobutamine stress testing is helpful in low gradient-low EF AS Importance of contractile reserve True AS vs Pseudo AS Absence of contractile reserve substantially increases operative mortality with AVR in low EF-low gradient AS But if patients survive, EF improves and outcome good

Thank You! mankad.sunil@mayo.edu Acknowledgements: Dr. Sharon Mulvagh